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Abstract
The varicella-zoster virus (VZV) re-activation increases during ageing. Although the effects of 
VZV re-activation are observed in the skin (shingles) the number or functional capacity of 
cutaneous VZV specific T cells have not been investigated. The numbers of circulating IFN-γ 
secreting VZV specific CD4+ T cells are significantly decreased in old subjects however other 
measures of VZV-specific CD4+ T cells, including proliferative capacity to VZV antigen 
stimulation and identification of VZV-specific CD4+ T cells with a MHC class II tetramer 
(epitope of IE-63 protein), were similar in both age groups. The majority of T cells in the skin of 
both age groups expressed CD69, a characteristic of skin resident T cells. VZV-specific CD4+ T 
cells were significantly increased in the skin compared to the blood in young and old subjects and 
their function was similar in both age groups. In contrast the number of Foxp3+ regulatory T cells 
(Tregs) and expression of the inhibitory receptor PD-1 on CD4+ T cells were significantly 
increased in the skin of older humans. Therefore VZV-specific CD4+ T cells in the skin of older 
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individuals are functionally competent. However their activity may be restricted by multiple 
inhibitory influences in situ.
Keywords
T cell; memory; skin resident; antigen-specific; ageing
INTRODUCTION
Varicella zoster virus (VZV), an alpha-herpes virus, is the causative agent of chickenpox. 
After resolution of the initial infection VZV enters a latent phase within dorsal root ganglia. 
However, later in life VZV re-activation can occur, causing herpes zoster (also known as 
shingles) that results from virus shedding into the skin (Arvin, 1996; Arvin, 2001; Goldblatt, 
1998). Although the skin is the major site that is involved in VZV reactivation during 
shingles, it is not clear if this is related to changes in skin resident VZV specific T cells in 
this tissue. The role of a subset of memory cells in the skin, termed tissue resident memory T 
cells (Trm), that are poised to provide efficient and rapid immunity in this organ has been 
described recently (Gebhardt et al., 2009; Gebhardt et al., 2011; Jiang et al., 2012). These 
Trm cells have been shown to be part of the first line of defence against herpes simplex virus 
(HSV) or human papiloma virus (HPV) infections (Cuburu et al., 2012; Gebhardt et al., 
2009; Mackay et al., 2012; Masopust et al., 2010; Tang and Rosenthal, 2010). The 
activation of these cells also enables the recruitment of circulating antigen-specific T cells 
that amplifies the response (Schenkel et al., 2013). Although most studies of Trm have 
focused on CD8+ populations (especially in mice), CD4+ Trm cells also reside in the skin 
(Clark et al., 2006; Clark et al., 2012; Mueller et al., 2013). In addition to the tissue resident 
Trm cells, skin also contains recirculating memory T cells which actively recirculate 
between blood, skin and lymphoid organs (Bromley et al., 2013; Clark et al., 2012; Jiang et 
al., 2012). It has been proposed that non-migrating tissue resident T cells express CD69 
which was found to be necessary for S1P1 down-regulation and T cell retention (Carbone et 
al., 2013; Skon et al., 2013).
We have investigated quantitative and qualitative changes in VZV specific CD4+ T cells in 
the blood and skin in young and old subjects and showed that although the numbers of these 
cells were increased in the skin compared to the blood, the capacity of these cells to secrete 
cytokines was not altered by ageing. The vast majority of T cells in the skin of both young 
and old individuals expressed CD69, a marker for tissue resident memory T cell populations 
(Clark et al., 2012; Gebhardt et al., 2009; Jiang et al., 2012) suggesting that VZV-specific 
CD4+ T cells in healthy skin may be Trm cells. Although cutaneous VZV specific T cells in 
old individuals are functionally competent, previous studies have shown that these subjects 
have decreased ability to mount a recall antigen responses to cutaneous VZV antigen 
challenge (Agius et al., 2009; Levin et al., 2003). Our results suggest that this decrease in 
cutaneous VZV-specific immunity in the tissue is not directly due to a defect in CD4+ Trm 
cells. Instead, external influences such as the increased numbers of suppressive Tregs (Agius 
et al., 2009; Seneschal et al., 2012) and/or increased signalling through the inhibitory 
receptor PD-1 (Wherry, 2011; Zajac et al., 1998), that is highly expressed on skin resident 
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CD4+ T cells, may create an inhibitory microenvironment that restricts effective immune 
responses to VZV in the skin of older humans.
RESULTS
VZV specific CD4+T cells in the blood during ageing
We investigated the effect of increasing age on VZV specific CD4+ T cell frequency by 
measuring IFN-γ and IL-2 responses following overnight stimulation of PBMC with VZV 
lysate. 133 donors were analysed (aged 20-91 years) and only donors serologically positive 
for VZV were included in the analysis. Figure 1A (left panel) shows representative dot plots 
of IFN-γ production for unstimulated and VZV stimulated PBMC gated on CD3+CD4+ T 
cells. We found a significant decrease of IFN-γ secreting cells during ageing (Figure 1A 
right panel, p<0.0001) confirming previous reports (Asanuma et al., 2000; Levin et al., 
2003). We also examined the IL-2 responses to VZV of the donors analysed (Supplementary 
Figure 1) but found that host age did not significantly influence the frequency of IL-2 
secreting cells.
We next investigated VZV specific T cell activity by assessing the ability of PBMC from 
young and old donors to proliferate after VZV antigen stimulation in vitro (Figure 1B, 1C). 
After 6 days of stimulation with a range of concentrations of VZV lysate (n=29 old and 26 
young) the extent of proliferation measured by 3H-thymidine uptake was similar in young 
and old subjects except at the lowest dose of VZV antigen used (Figure 1B). Furthermore 
there were no differences in proportions of cells expressing Ki67 three days after VZV 
lysate stimulation (4 μl/ml) in vitro (Figure 1C). This indicates that the decrease in VZV 
specific cells, identified by IFN-γ secretion in the peripheral blood compartment, does not 
represent a global defect in the functional responses of these cells.
We also investigated the frequency of VZV specific cells in young and old subjects (Figure 
1D) using a class II tetramer HLA-DRB1*1501 restricted IE63 tetramer (Jones et al., 2007; 
Vukmanovic-Stejic et al., 2013). No difference was observed in the number of tetramer 
positive VZV specific CD4+ T cells between the young and old individuals tested (Figure 
1D). We confirmed that the tetramer staining was specific by showing an absence of staining 
when a control tetramer (CLIP) was used, and also when HLA DRB1*1501-negative 
individuals were tested (data not shown and (Vukmanovic-Stejic et al., 2013)).
Effect of age on leukocyte populations and global gene expression signatures in the skin
We investigated if there were numerical or functional differences in the T cells found in 
young and old skin. We collected 5 mm punch biopsies from individuals of both age groups 
and analysed them by immunohistochemistry and immunofluorescence using antibodies 
specific for CD3, CD4, CD11c, CD163 and Foxp3 (Figure 2A). No difference was observed 
in the number of CD3+, CD4+ or CD8+ T cells with age (Figure 2B, Table 1). The numbers 
of dermal dendritic cells (CD11c) or macrophages (CD163) (Haniffa et al., 2009; Zaba et 
al., 2007; Zaba et al., 2008) were also unaffected by increasing age (Figure 2B, Table 1). 
However there were significantly increased numbers of CD4+Foxp3+ T cells in the skin of 
old compared to young individuals in agreement with previous studies (Agius et al., 2009; 
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Gregg et al., 2005; Lages et al., 2008). This difference was also observed by flow 
cytometric analysis of skin derived populations (Supplementary Figure 2A) The increased 
proportion of Foxp3+ cells in the old skin is significantly correlated with a decrease of 
memory CD4+ T cell infiltration and with the decrease in the clinical response after 
intradermal challenge with VZV antigen (Figure 2C, Supplementary Figure 2) confirming 
previous observations (Agius et al., 2009; Vukmanovic-Stejic et al., 2013). This is indirect 
evidence that these cells in older subjects have suppressive activity.
We next investigated global gene expression profiles in the skin of young and old subjects. 
Transcriptional analysis was performed on the skin biopsies of normal skin collected from 7 
young and 7 healthy old individuals. Overall, unsupervised clustering coupled with 
bootstrapping did not identify stable clusters separating skin samples from young and old 
individuals (Figure 2D and Supplementary Figure 3A). Only 2 genes were considered 
differentially expressed LPPR4 (higher in young) and ADAMTSL1 (higher in old) using a 
typical FDR<0.05 and FCH>2. In terms of pathways, Gene Set Variation Analysis (GSVA) 
suggested differences in human skin pigmentation genes and cell cycle related genes (Wang 
et al., 2013) but not in terms of immune genes, positive or negative regulators or in any of 
the skin specific cytokine pathways that we have curated (Suarez-Farinas et al., 2011) 
(Supplementary Figure 2C).
Next, the global gene expression profiles in the young and aged skin samples were 
compared with that of a large collection of microarray data sets from distinct human primary 
cell populations (745 individual data sets) (Mabbott et al., 2013). Data were analysed using 
Biolayout Express3D with a Pearson correlation r=0.90 and Markov cluster (MCL) of 2.2,, 
and generated 140 clusters of ≥6 probe sets (genes). The network graph’s structure is 
derived from the clustering of genes that are expressed in a cell- or function-specific manner 
(Supplementary Figure 3D; Supplementary Table 1) and their contents reflect the nature of 
the cell populations represented in human skin. Congruent with the differential 
transcriptional analyses presented above (Supplementary Figure 3B, C), no significant 
difference was observed in the expression levels of the genes within these cell-specific (eg: 
keratinocytes, endothelium) and cellular activity-related clusters (eg: extracellular matrix, 
MHC genes) between the two age groups (Supplementary Figure 3E).
Effect of age on the extent of differentiation of CD4 T cells in blood and skin
We investigated whether the T cells in skin were true skin resident T cells as defined by 
CD69 expression that is a marker for tissue retention(Clark et al., 2012; Gebhardt et al., 
2009; Jiang et al., 2012; Skon et al., 2013), In contrast to circulating T cells 80-90% of skin 
derived CD4 (Figure 3A, 3B) and CD8 populations (data not shown) express CD69. In 
addition, only around 10% of skin derived cells express CCR7 confirming that the vast 
majority of cutaneous T cells are skin resident and not transient T cell populations (Clark et 
al., 2012; Gebhardt et al., 2009; Jiang et al., 2012). Furthermore CD69+ T cells did not 
express surface CD25 suggesting they were not an activated population and this was also 
confirmed by their small size, defined by forward and side scatter properties by flow 
cytometry. There was no significant change in the proportion of CD69+ cells with age 
(Figure 3B).
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To determine whether excessive differentiation towards an end stage could reflect altered T 
cell function in the skin compared to T cells in peripheral blood we collected paired blood 
and skin samples from young and old individuals (n=23 old and n=31 young for CD4, n=10 
old and 14 young for CD8). Based on their expression of surface CD45RA, CD27, CD4 
(Figure 3C, D) and CD8 (Supplementary Figure 4A, B) T cells from both blood and skin can 
be subdivided into 4 subsets. The CD45RA+CD27+ population is the least differentiated and 
has the longest telomeres, CD45RA−CD27+ cells have intermediated telomere lengths while 
both CD45RA−CD27− and CD45RA+CD27− cells have relatively short telomeres and 
express multiple other characteristics of senescence (Di Mitri et al., 2011; Henson et al., 
2014; Libri et al., 2011). In both young and old subjects, cutaneous T cells in both CD4+ 
(Figure 3C, D) and CD8+ populations (Supplementary Figure 4A, B) showed a significant 
decrease in the undifferentiated CD45RA+CD27+ population with a concomitant increase in 
CD27+CD45RA− and CD45RA−CD27− cells. In older subjects, the proportion of 
CD45RA−CD27− cells was significantly higher within skin CD4 and CD8 compartments 
compared to young subjects (Figure 3).
We next investigated the functional capacity of skin resident T cells isolated from punch 
biopsies. Following a 6 hour stimulation with PMA and ionomycin cells were stained for 
IL-2, IFN-γ, TNF-α and IL-22. There were no significant differences in the capacity of 
CD4+ (Figure 3 E, F) or CD8+ T cells from the skin of young and old individuals to secrete 
these inflammatory cytokines after stimulation in vitro (Supplementary Figure 4, D).
VZV-specific skin resident T cells in young and old subjects
We next investigated the phenotypic and functional characteristics of VZV specific T cells 
in both the skin and blood of young and old subjects. Skin T cells isolated from punch 
biopsies, and paired blood samples, were tested for their ability to synthesize IFN-γ, TNF-α 
and/or IL-2 after overnight re-stimulation with VZV lysate as previously described 
(Vukmanovic-Stejic et al., 2013). Minimal IFN-γ or IL-2 was produced by blood or skin 
CD4+ T cells in the control cultures without added VZV antigens (not shown). We could 
identify cytokine producing CD4+ cells in skin of > 60% of young and old individuals tested 
(positive staining for one or more cytokines, Figure 4A). In those individuals where VZV 
specific cells were found in both compartments, there were significantly higher proportions 
of these cells in the skin (Figure 4A, 4B, p=0.001, Wilcoxon paired test, n=9 old and 15 
young). The observed difference was not accounted for by the difference in the 
differentiation state of skin versus blood CD4 T cells as there was a significantly increased 
proportion of VZV-specific cells in skin compared to the circulating memory compartment. 
When the proportion of cytokine secreting VZV-specific CD4+ cells was compared between 
the skin of young and old individuals, no significant difference was observed (Figure 4C). 
Therefore there is no obvious age-associated reduction in the number of cytokine secreting 
VZV specific CD4+ T cells in the skin.
We also investigated the characteristics of VZV specific CD4+ T cells in the skin that were 
identified by class II tetramer binding. Paired samples of cells isolated from skin biopsies 
and PBMC were stained with an HLA-DRB1*1501 restricted IE63 tetramer (Jones et al., 
2007). The representative tetramer staining is shown in Figure 4D (left panels). Increased 
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proportions of VZV-specific CD4+ T cells were detected in the skin when compared to the 
blood in both old and young individuals (Figure 4D, Wilcoxon paired test, p=0.06 in young 
n=6; and p=0.008 in the old; n=5). The specificity of tetramer staining was confirmed as 
described above (Vukmanovic-Stejic et al., 2013). Therefore, using either intracellular 
cytokine staining or tetramer binding we found higher proportions of VZV specific CD4+ T 
cells in the skin than in blood of both young and old individuals, however there were no 
differences between the age groups in either compartment.
We next compared the differentiation state of skin resident VZV specific CD4+ T cells 
between young and old individuals. Overall, VZV specific cells identified in the skin are 
predominantly of the CD45RA−CD27+ and CD45RA−CD27− phenotype (Figure 4E) similar 
to that seen in blood (Supplementary Fig 5) in both age groups. Furthermore there was a 
significant increase in CD45RA+CD27− T cells, that have characteristics of end-stage 
differentiation or senescence (Di Mitri et al., 2011; Henson et al., 2014; Libri et al., 2011) 
within the VZV-specific population in the old compared to young skin. The phenotype of 
tetramer positive cells in skin was similar to that observed when cytokine secreting VZV 
specific cells were analysed (Supplementary Fig 5C). In conclusion, VZV specific CD4+ T 
cells in blood and in skin are functional and are not restricted by excessive differentiation.
Expression of PD-1 in skin during ageing
Since the numbers of skin resident VZV specific CD4+ T cells are not decreased during 
ageing and they are able to secrete cytokines in response to VZV antigen challenge in vitro, 
other factors may contribute to the impaired skin recall response to VZV antigen challenge 
in older subjects and to their increased susceptibility to shingles (Agius et al., 2009; Levin et 
al., 2003; Tang et al., 2012; Weinberg et al., 2010). The progressive loss of cytokine 
production and proliferative activity by CD4+ T cells as a result of chronic immune 
stimulation during persistent viral infections and cancer is associated with the expression of 
PD-1 and other inhibitory receptors (Wherry, 2011; Zajac et al., 1998). Blockade of these 
receptors can reverse these functional defects in these cells (Kamphorst and Ahmed, 2013). 
We therefore investigated whether there was increased expression of the T cell surface 
inhibitory receptor PD-1 in blood compared to skin cells during ageing. Paired blood and 
normal skin samples stained for the expression of PD-1 on CD4 (n= 17; 6 young, 6 middle 
aged, 5 old) and CD8+ T cells (n=−12; 4 young, 3 middle aged, 5 old). (Figure 5A, B). 
There was a highly significant increase in PD-1 expression on skin resident compared to 
circulating T cells (p < 0.001, Wilcoxon paired test). PD-1 expression was increased in both 
blood and skin during ageing (Figure 5C) with as many as 40% of CD4+ T cells being 
positive in the skin. This data suggests that T cells in the skin of old humans may be more 
susceptible to inhibition through PD-1 signalling.
DISCUSSION
Recent studies have shown that skin resident memory T (Trm) cells play an important role in 
providing protection against re-exposure to, or re-activation of, local persisting pathogens 
(Clark et al., 2012; Cuburu et al., 2012; Gebhardt et al., 2009; Mackay et al., 2012; 
Masopust et al., 2010; Mueller et al., 2013; Tang and Rosenthal, 2010). Furthermore, these 
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Trm cell populations may be regulated independently of the circulating memory T cell pools 
of cells (Carbone et al., 2013; Clark et al., 2012; Gebhardt et al., 2011; Mueller et al., 2013; 
Schenkel et al., 2013). Considering the skin manifestation of both primary and secondary 
varicella disease, it is unusual that VZV specific T cells have only previously been studied 
in the peripheral blood (Asanuma et al., 2000; Hayward and Herberger, 1987; Patterson-
Bartlett et al., 2007; van Besouw et al., 2012; Weinberg and Levin, 2010). We first 
investigated whether there was a general decrease in the number or functional capacity of 
skin resident T cells in older subjects. Based on the expression of CD69, that was expressed 
by almost all skin derived CD4 and CD8 T cells, together with the lack of CCR7 expression 
and the fact that skin biopsies were collected from normal, unchallenged skin we concluded 
that our skin derived cells represent a skin resident population (Clark et al., 2012; Gebhardt 
et al., 2009; Jiang et al., 2012; Skon et al., 2013). However contribution of recirculating T 
cells transiently patrolling the skin cannot be completely discounted (Zhu et al., 2013). A 
key observation was that there were significantly more VZV specific CD4+ T cells in the 
skin compared to the blood in both young and old individuals. Since the skin contains more 
T cells than the blood (Clark, 2010; Clark et al., 2006), the decrease in VZV-specific T cells 
in the circulation during ageing may not represent a global decrease of these cells in vivo as 
they may simply have re-located to the skin. This observation coupled to the fact that other 
methods of evaluating VZV-specific T cells do not indicate a reduction of these cells in the 
blood suggests that there may not be a general defect of VZV-specific T cell numbers or 
function during ageing.
We found no differences in numbers of dendritic cells and macrophages between both age 
groups, and transcriptional profiling of young and old normal skin did not show any 
significant differences in the genes involved in mononuclear phagocyte function or immune 
responses. Therefore the general skin microenvironment at a steady state appears very 
similar in young and old individuals suggesting that the reduced recall response to antigen in 
the skin during ageing (Agius et al., 2009) probably occurs downstream of antigen 
challenge.
We investigated whether Trm cells in the skin of older humans were inhibited in situ, as this 
could explain why there is a reduced recall response to VZV skin test antigen challenge and 
also the predisposition to VZV reactivation in vivo. We showed previously that Foxp3+ 
Tregs that are identified in the skin are suppressive and there is a significant inverse 
correlation between the number of these cells present and the size of the delayed type 
hypersensitivity response after VZV challenge ((Vukmanovic-Stejic et al., 2013) and Figure 
2C, Supplementary Figure 2). The increase in Tregs during ageing has also been observed in 
the blood of normal subjects (Gregg et al., 2005; Vukmanovic-Stejic et al., 2006) and has 
also been reported in the tissues of old mice (Lages et al., 2008; Raynor et al., 2012). This 
supports the possibility that the increase in Treg cell numbers and their suppressive activity 
may contribute to decreased VZV specific responses in older subjects.
Signalling through PD-1 and other inhibitory receptors can inhibit T cell responses both in 
vitro and in vivo (Wherry, 2011; Zajac et al., 1998). The blockade of these receptors can 
reverse these functional defects in these cells and this has led to the use of PD-1 blocking 
strategies in the treatment of melanoma and other skin cancers (Flemming, 2012; Kamphorst 
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and Ahmed, 2013; Lu et al., 2014). In addition, it has been shown recently that interplay 
between Tregs and PD-1 signalling regulates immune responsiveness and the control of viral 
infection in vivo (Penaloza-MacMaster et al., 2014). We observed very high PD-1 
expression on skin compared to blood T cells that increased with age. This suggests that 
inhibitory signalling by different mechanisms may actively regulate immune responsiveness 
in the skin, especially during ageing. The reason for the increase in Treg numbers or PD-1 
expression in the skin during ageing is unclear. It has been shown previously that infection 
with persistent viruses such as CMV in humans can induce PD-1 expression and it is 
possible that more of the old subjects we have studied are CMV+ than the young cohort 
(Henson et al., 2014). Alternatively, these changes may be linked to the increased 
inflammation (inflammageing) that is observed in elderly subjects (Franceschi et al., 2000).
Our studies highlight the importance of studying human immunity in additional 
compartments to peripheral blood. The availability of a vaccine (Zostavax) to prevent herpes 
zoster in older subjects has reduced the incidence of shingles in the elderly (Gershon, 2007; 
Levin et al., 2008; Weinberg et al., 2009) although efficacy of the vaccine is only 38% in 
the very old (>80yrs). This indicates that it is essential to study the mechanisms that are 
responsible for the declining immunity during ageing to rationalize ways by which 
immunity in general and vaccine responses in particular could be improved in the elderly.
MATERIALS AND METHODS
Subjects
Healthy individuals who had a history of previous chickenpox infection (n=94, median age 
= 32.5 years, age range 20-92 years, 38 male, 56 female) were recruited for the study. 
Subjects were grouped as young <40, middle aged 40-65 and old >60 years old. This work 
was approved by the Ethics Committee of the Royal Free Hospital, London. All volunteers 
provided written informed consent and study procedures were performed in accordance with 
the principles of the declaration of Helsinki. Individuals with history of neoplasia, 
immunosuppressive disorders or inflammatory skin disorders and individuals on 
immunosuppressive medication were excluded. In some cases skin from healthy individuals 
was obtained from donors undergoing routine plastic surgery at Guy’s and St. Thomas’ 
hospitals (approved by the Institutional Review Board of Guy’s Hospital). To examine the 
clinical response to VZV, healthy individuals were injected intradermally with Varicella 
Zoster Virus (VZV) skin test antigen from The Research Foundation for Microbial Diseases 
of Osaka University (BIKEN) as described previously(Agius et al., 2009; Vukmanovic-
Stejic et al., 2011).
Skin biopsies
Punch biopsies (5 mm diameter) from the upper volar region of the forearm were obtained 
from 30 young and 25 old volunteers. Biopsies were frozen in optimal cutting temperature 
compound (OCT, Bright Instrument Company Ltd, Huntingdon, Uk). 6 μm sections were 
cut and then fixed in ethanol and acetone and stored at −80°C. For functional analysis of 
skin cells 5 mm punch biopsies were digested overnight with 0.8mg/ml of collagenase IV 
(Sigma Aldrich, Gillingham, UK) as described (Vukmanovic-Stejic et al., 2013). For the 
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analysis of the DTH response to VZV challenge skin biopsies were collected at different 
times post injection, frozen and used for histological analysis (Agius et al., 2009).
PBMC preparation
Heparinized blood samples were collected from healthy volunteers and patients with acute 
disease. PBMCs were prepared by density centrifugation on Ficoll-Paque (Amersham 
Biosciences, Little Chalfont, UK) and re-suspended in complete medium.
Flow Cytometric Analysis
Multi-parameter analysis of skin and blood T cell phenotype was performed on LSR II or 
BD Fortessa using FACS Diva software (both BD Biosciences, Oxford, UK) and further 
analyzed using FlowJo software (TreeStar, Inc) as previously described (Agius et al., 2009; 
Vukmanovic-Stejic et al., 2013). PBMCs or skin cells were stained with different 
combinations of antibodies including CD3, CD4, CD8, CD45RA, CD28, CD27 (BD 
Biosciences) Ki67, CLA, CCR7 and PD-1 (clone EH12.2H7; Biolegend, London, UK). All 
surface staining was performed for 30 minutes on ice. Isotype control staining and FMO 
controls were used to set the quadrants. Ki67 staining (clone B56, BD Bioscience) was 
performed by intracellular staining using the Foxp3 Staining Buffer Set (Miltenyi Biotec, 
Bisley, UK). For intracellular cytokine staining cells were stimulated with VZV lysate 
(Virusys corporation, Taneytown, MD) or SEB as positive control and incubated for 15 
hours at 37°C, 5% CO2 in the presence of 5 μg/ml Brefeldin A (Sigma-Aldrich, Gillingham, 
UK). Unstimulated controls were always included. Following stimulations cells were stained 
for surface markers for 30 minutes at 4°C, washed, fixed and permeabilised (Fix & Perm 
Cell Permeabilisation Kit, Invitrogen, Paisley, UK) before staining for IL-2, IFN-γ and 
TNF-α (all from BD Biosciences, Oxford, UK).
Tetramer staining
Tetramer staining was performed as previously described using DRB1*1501 iTAg MHCII 
tetramer complexed to VZV IE63 peptide 24 (QRAIERYAGAETAEY) (Beckman Coulter, 
High Wycombe, UK); CLIP peptide (PVSKMRMATPLLMQA) was used as a control 
(Jones et al., 2007; Vukmanovic-Stejic et al., 2013). Briefly, cells were first incubated with 
2 μg/ml HLA Class II tetramers for 1-2 hours at 37°C in the dark, washed in PBS and then 
stained for different surface markers as needed. We analysed the tetramer expression within 
the CD4+ T cell subset by gating on the lymphocytes and excluding B cells, monocytes and 
dead cells (Via-Probe positive population).
Immunofluorescence
6 μm skin sections collected from normal or VZV injected skin were blocked with Dako 
non-serum protein block for 20 minutes, followed by incubation with primary antibodies 
(biotin anti-human Foxp3 and mouse anti-human CD4) overnight at 4°C, followed by 
incubation with strepCy3 and anti-mouse IgG1 Alexa Fluor 488 for 1hr at room temperature 
as described (Vukmanovic-Stejic et al., 2008). Cell numbers were expressed as the mean 
absolute cell number per perivascular infiltrate where 5 largest perivascular infiltrates 
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present in the upper and mid dermis of each section were counted (Vukmanovic-Stejic et al., 
2008).
Immunohistochemistry
Skin sections from normal skin (n=6 young, n=6 old) were stained with purified mouse anti-
human CD3 antibody, purified mouse anti-human CD8 antibody (both Dakocytomation, 
Ely, UK), purified mouse anti-human CD4 and CD11c antibodies (BD Biosciences, Oxford, 
UK) or purified mouse anti-human CD163 antibody (Acris, Herford, Germany). Sections 
were counterstained using rabbit anti-mouse horseradish-peroxidase conjugated antibody 
(Dakocytomation, Ely, UK) and immunostaining revealed using chromagen 3′-
diaminobenzidine tetrahydrochloride. The number of positive cells/mm2 was counted 
manually using computer-assisted image analysis (NIH Image 6.1; http://rsb.info.nih.gov/
nih-image).
Transcriptional analysis
3 mm punch biopsies were collected from young and old individuals and immediately frozen 
in RNAlater and stored at −20°C until use. Tissues were homogenized and total RNA 
extracted using RNeasy Mini Kit (Qiagen, Manchester, UK). Target amplification and 
labelling was performed according to standard protocols using Nugen Ovation WB Kit. 
RNA was hybridized to Affymetrix Human Genome U133 2.0 plus arrays. Affymetrix gene 
chips were scanned for spatial artefacts using the Hirshlight package (Suarez-Farinas et al., 
2005). Gene expression measures were obtained using the GCRMA algorithm (Wu and 
Irizarry, 2004). Group comparisons were made using the moderated t-test and P-values were 
adjusted for multiple hypotheses using the Benjamini-Hochberg procedure.
Network analysis of the genes expressed within skin samples and in various human cell 
populations was performed as described previously (Mabbott et al., 2013). Briefly, human 
skin-punch microarray data were combined with a large collection of other primary cell 
gene-expression data sets (745 individual microarray data sets), available from the GEO 
database on the Affymetrix Human Genome U133 Plus 2.0 expression array platform 
(GSE49910) and analysed using Biolayout Express3D software (Freeman et al., 2007). The 
graph of these data was then explored to understand the significance of the gene clusters, 
identify those expressed by the young and old skin samples and their functional relationships 
to the other cell populations represented.
Statistics
Statistical analysis was performed using GraphPad Prism version 6.00 for Windows 
(GraphPad Software, San Diego, California, USA). Non-parametric tests were 
predominantly utilised as data sets were not normally distributed. The Wilcoxon matched 
pairs test or a paired t-test was used when comparing two groups of matched data and a 2-
tailed Mann-Whitney test was used when comparing two unpaired groups.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Effect of age on circulating VZV specific CD4+ T cells
(A) FACS analysis of intracellular IFN-γ staining following overnight stimulation with VZV 
viral lysate in the presence of brefeldin A. Representative dot plots of the CD4+ IFN-γ 
response from young and old donors are shown and unstimulated control. Cumulative data 
for all donors are plotted as increasing age (years) on the x axis against the percentage of 
antigen specific IFN-γ+ CD4+ T cells. Line of best fit was generated by linear regression and 
the correlation assessed by Spearman rank correlation. (B) PBMC were stimulated with a 
range of doses of VZV lysate and cell proliferation measured on day 7. (C) PBMCs from 
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young and old individuals were stimulated with VZV lysate for 72 hours and then stained 
for the expression of Ki67, CD4 and CD8 and analysed by FACS. Data are expressed as % 
of CD4+ or CD8+ T cells expressing Ki67 above background (unstimulated PBMC) (n=20 
young and old, horizontal line represents the mean). (D) The number of antigen specific 
CD4+ cells was also determined by class II tetramer staining. PBMC were stained with 
HLA-DRB1*1501 restricted IE63 tetramer and with CLIP control (Jones et al., 2007; 
Vukmanovic-Stejic et al., 2013). Each data point represents one individual (n=5 young and 
old individuals, mean and SEM are indicated).
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Figure 2. Effect of age on the skin resident populations and gene expression profiles
Punch biopsies (5 mm) were collected from normal skin of healthy young (<40 years old) 
and old (>70 years old) volunteers. (A) Sections were stained to detect CD4, CD8, CD3, 
CD163, CD11c and Foxp3 (scale bar= 100μm). Cell numbers were expressed as the mean 
absolute number of cells counted within the section. The frequency of Foxp3+CD4+ cells 
was confirmed by 3 colour IF staining (Dapi- blue, CD4-green, Foxp3- red, scale 
bar=10μm). (B) Graph shows numbers of different cell populations in young and old skin 
(n=5-7 young and old). Biopsies were collected following intradermal challenge with VZV 
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antigen and stained for CD4 and Foxp3. Numbers of cells were counted in perivascular 
infiltrates (average of 5 largest perivascular infiltrates (PV) counted). Graph shows an 
inverse correlation between the proportion of Foxp3+ cells within CD4 population and a size 
of the cellular infiltrate (C) (filled circles-young, open circles-old). (D) Unsupervised 
clustering of the skin samples from young (labels in red) and old (labels in blue) individuals 
based on the expression profiles using Affymetrix HG U133 Plus 2.0 arrays.
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Figure 3. Effect of age on the phenotype and function of skin resident T cells
5 mm punch biopsies and peripheral blood samples were collected from n=31 young and 
n=23 old donors. (A) Representative FACS histograms showing ex vivo CD69 expression in 
CD4+ T cells in skin compared to the blood. Comparison of percentages of PD-1 expressing 
cells CD4+ or CD8+ T cells between skin and blood of the same donors (p<0.001 Wilcoxon 
paired test). (B) Cumulative data showing percentages of CD69 expressing cells amongst 
blood and skin derived CD4+ T cells, stratified by donor age. Spearman correlation was used 
to calculate significance and deviation from zero. (C) Skin cells and PBMC were stained 
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with CD4, CD45RA and CD27 to identify 4 differentiation subsets. Representative FACS 
staining of PBMC (top panels) and skin derived cells (bottom panels) from young and old 
donors, is shown gated on the CD3+CD4+ cells. (D) Bar chart shows cumulative data for in 
young and old individuals. Statistical analysis of blood and skin populations was performed 
using a paired t-test and p-values are indicated where relevant. (E) Skin derived leukocytes 
were stimulated for 5 hours with PMA and ionomycin in the presence of brefeldin A and 
stained for CD4, IFN-γ, IL-2, TNF-α and IL-22. Representative dot plots are shown, gated 
on CD4+ cells (NS, non stimulated; PMA+Iono, PMA and ionomycin). (F) Graphs show % 
of CD4+ cells staining positive for a particular cytokine (n=5-7 young and old for each 
cytokine).
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Figure 4. Frequency of VZV specific CD4+ T cells is higher in the skin compared to blood and is 
not affected by age
5 mm punch biopsies and peripheral blood samples were collected from healthy young and 
old volunteers. Skin cells and PBMC were stimulated with VZV lysate overnight and 
stained for intracellular cytokines-IL-2, IFN-γ and TNF-α. (A) Representative dot plots of 
the CD4+ IFN-γ and TNF-α response from young and old donors are shown. (B) Graph 
shows comparison of the frequency of cytokine secreting cells between PBMC and skin 
samples (n=9 old and 15 young, p=0.001 Wilcoxon paired test) each symbol represents a 
different individual. (C) Graph shows frequency of IFN-γ, IL-2 and TNF-α secreting VZV 
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specific cells in young and old individuals (n≥8 young and old depending on cytokine). (D) 
In HLA-DR15+ donors PBMC and skin derived cells were stained with HLA-DRB1*1501 
restricted IE63 tetramer. Representative FACS staining is shown on the left. Bar graph 
represents cumulative data (n=6 young and 5 old individuals, mean and SE and p values are 
indicated, Wilcoxon paired test). (E) The phenotype of skin resident VZV specific IFN-γ+ 
CD4 T cells was compared between young (n=12) and old individuals (n=7).
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Figure 5. Ex vivo PD-1 expression in skin and blood derived CD4+ and CD8+ T cells
PD-1 expression was measured by FACS in PBMCs or collagenase digested skin cells 
derived from healthy individuals (n=34, age range 19-89). (A) Representative FACS 
histograms showing ex vivo PD-1 expression in CD4+ and CD8+ T cells in skin compared to 
the blood. (B) Comparison of percentages of PD-1 expressing cells amongst total CD4+ or 
CD8+ T cells between skin and blood of the same donors (p<0.001 Wilcoxon paired test). 
(C) Cumulative data showing percentages of PD-1 expressing cells amongst blood and skin 
derived CD4+ T cells, stratified by donor age. Spearman correlation was used to calculate 
significance and deviation from zero (* p>0.05).
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Table 1
Numbers of different cell populations is normal skin
Cell type Marker used Range and mean (young) Range and mean (old) different
T cells CD3 44-201, 131.8 91-291, 160.6 no
CD4+ T cells CD4 66-145, 93.4 45-159, 103 no
CD8+ T cells CD8 11-74, 41.6 24-110, 52,2 no
Tregs Foxp3 1-17, 11.6 17-50, 32.8 0.0095
Dendritic cells CD11c 46-105, 73.5 33-83, 52.75 no
Macrophages CD163 95-326, 192.8 199-390, 278.2 no
PDC BDCA3 18-33, 27.4 13-41, 25.75 no
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